Diclofenac sodium 1 MG/ML Ophthalmic Solution — RxCUI 854801
RxNorm drug concept · Semantic clinical drug
RxCUI 854801
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
10 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI854801
Official nameDiclofenac sodium 1 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdiclofenac sodium 0.1 % Ophthalmic Solution
FDA products mapped6
Package NDCs mapped10
Reported Medicaid activity (SDUD)16,149 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diclofenac Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- They calm inflammation after cataract surgery. They also temporarily ease pain and light sensitivity after corneal refractive surgery, such as PRK or radial keratotomy.
- After cataract surgery, it is usually about 4 times a day, starting the day after surgery for the first 2 weeks. For refractive surgery, you use drops before and right after the pr...
- Brief burning or stinging is the most common complaint, affecting about 15% of people. It usually passes quickly. Tell your doctor if it persists or you notice blurred vision, redn...
- Be careful and tell your doctor first. People sensitive to aspirin or other NSAIDs may also react to diclofenac. You should not use the drops if you are allergic to any ingredient...
🕸️ Concept Web — How Diclofenac sodium 1 MG/ML Ophthalmic Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Diclofenac sodium 1 MG/ML Ophthalmic Solution
RxCUI 854801 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Diclofenac
3355IN -
Diclofenac sodium
203214PIN
-
Diclofenac
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Diclofenac Ophthalmic Solution
378986SCDF -
Diclofenac sodium Ophthalmic Solution
2646673SCDFP -
Diclofenac Ophthalmic Product
1151150SCDG -
Diclofenac sodium Ophthalmic Product
2662606SCDGP -
Ophthalmic Solution
7670DF -
Ophthalmic Product
1151135DFG
-
Diclofenac Ophthalmic Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Diclofenac sodium 1 MG/ML
854800SCDC
-
Diclofenac sodium 1 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Diclofenac sodium 1 MG/ML
SCDC · 854800 -
Diclofenac Ophthalmic Solution
SCDF · 378986 -
Diclofenac sodium Ophthalmic Solution
SCDFP · 2646673 -
Diclofenac Ophthalmic Product
SCDG · 1151150 -
Diclofenac sodium Ophthalmic Product
SCDGP · 2662606
📦 FDA Products & Package NDCs
6 products · 10 package NDCs
10 package NDCs map to RxCUI 854801 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 24208-0457-05 | 1 BOTTLE, DROPPER in 1 CARTON (24208-457-05) / 5 mL in 1 BO... | Diclofenac Sodium | Bausch & Lomb Incorporated | 2007-12-28 |
| 24208-0457-25 | 1 BOTTLE, DROPPER in 1 CARTON (24208-457-25) / 2.5 mL in 1... | Diclofenac Sodium | Bausch & Lomb Incorporated | 2007-12-28 |
| 50090-2454-00 | 1 BOTTLE, DROPPER in 1 CARTON (50090-2454-0) / 5 mL in 1 BO... | Diclofenac Sodium | A-S Medication Solutions | 2016-08-12 |
| 50090-3568-00 | 5 mL in 1 BOTTLE (50090-3568-0) | Diclofenac Sodium | A-S Medication Solutions | 2018-08-31 |
| 59390-0149-02 | 1 BOTTLE, DROPPER in 1 CARTON (59390-149-02) / 2.5 mL in 1... | Diclofenac | Altaire Pharmaceuticals Inc. | 2015-11-16 |
| 59390-0149-05 | 1 BOTTLE, DROPPER in 1 CARTON (59390-149-05) / 5 mL in 1 BO... | Diclofenac | Altaire Pharmaceuticals Inc. | 2015-11-16 |
| 61314-0014-05 | 1 BOTTLE in 1 CARTON (61314-014-05) / 5 mL in 1 BOTTLE | Diclofenac Sodium | Sandoz Inc | 2018-02-14 |
| 61314-0014-25 | 1 BOTTLE in 1 CARTON (61314-014-25) / 2.5 mL in 1 BOTTLE | Diclofenac Sodium | Sandoz Inc | 2018-02-14 |
| 72888-0150-21 | 1 BOTTLE in 1 CARTON (72888-150-21) / 2.5 mL in 1 BOTTLE | DICLOFENAC SODIUM | Advagen Pharma Ltd | 2025-04-30 |
| 72888-0150-22 | 1 BOTTLE in 1 CARTON (72888-150-22) / 5 mL in 1 BOTTLE | DICLOFENAC SODIUM | Advagen Pharma Ltd | 2025-04-30 |
Observed labelers:
A-S Medication Solutions (2) ·
Advagen Pharma Ltd (2) ·
Altaire Pharmaceuticals Inc. (2) ·
Bausch & Lomb Incorporated (2) ·
Sandoz Inc (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.